Literature DB >> 7036849

Clinical pharmacokinetics of sulphonamides and their N4-acetyl derivatives.

C A Hekster, T B Vree.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7036849     DOI: 10.1159/000400131

Source DB:  PubMed          Journal:  Antibiot Chemother (1971)        ISSN: 0066-4758


× No keyword cloud information.
  5 in total

1.  Pharmacokinetic properties of conventional and double-dose sulfadoxine-pyrimethamine given as intermittent preventive treatment in infancy.

Authors:  Sam Salman; Susan Griffin; Kay Kose; Nolene Pitus; Josephine Winmai; Brioni Moore; Peter Siba; Kenneth F Ilett; Ivo Mueller; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

2.  Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women.

Authors:  Harin A Karunajeewa; Sam Salman; Ivo Mueller; Francisca Baiwog; Servina Gomorrai; Irwin Law; Madhu Page-Sharp; Stephen Rogerson; Peter Siba; Kenneth F Ilett; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

3.  Effects of methoxy groups in the NI-substituent of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and mechanisms of renal excretion of sulfisomidine, sulfamethomidine and sulfadimethoxine.

Authors:  T B Vree; Y A Hekster; M W Tijhuis; M Baakman; M J Oosterbaan; E F Termond
Journal:  Pharm Weekbl Sci       Date:  1984-08-24

4.  Isolation and identification of 4-hydroxysulfamerazine and preliminary studies on its pharmacokinetics in dogs.

Authors:  T B Vree; M W Tijhuis; J F Nouws; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1984-04-27

5.  The effect of the molecular structure of closely related N1-substituents of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and renal clearance related to the structure of sulfadiazine, sulfamerazine and sulfadimidine.

Authors:  T B Vree; Y A Hekster; M W Tijhuis; M Baakman; T J Janssen; E F Termond
Journal:  Pharm Weekbl Sci       Date:  1983-04-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.